News Formal

Drug companies are still focused on raising prices, but some in the industry realize things need to change

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Health care executives gave no indication to bankers and investors at this year's J.P. Morgan Healthcare Conference that their pricing practices would change any time soon.

 

コメントありがとうございます。コメントは審査後に公開されます。

Liquid or syrup supplements.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 729. in JP

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

House Democrats launch drug-pricing probe into a dozen major health-care companiesAbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi and Teva Pharmaceuticals received letters seeking detailed information and documents about the companies' pricing practices. Why are they being investigated when Trump claimed that drug prices are at an all time low? I just hope the Democrats don't just waste taxpayer dollars with meaningless politically motivated crap like everyone expects them to. This seems a needed topic, but stay away from political theater Democrats. Just watch the SJC in 2018 if you want to see your embarrassment. Nice to see them investigating actual wrong doing and not just investigating HRC again.
ソース: CNBC - 🏆 12. / 72 続きを読む »

Analysis | The Health 202: Health-care industry preps offense against Medicare-for-AllThe Health 202: Health-care industry preps offense against Medicare-for-All Can't cure patients, that hurts long term profits! It's Tuesday.
ソース: washingtonpost - 🏆 95. / 72 続きを読む »